Skip to main content


We're creating a new version of this page. See preview

  • Meeting abstract
  • Open Access

EHMTI-0396. Reappearance of high fever on migraine patients, after individualized homeopathic treatment, is a valuable prognostic factor

  • 1,
  • 1 and
  • 2
The Journal of Headache and Pain201415 (Suppl 1) :M7

  • Published:


  • Migraine
  • Wilcoxon Sign Rank Test
  • Public Hospital
  • Potential Adverse Effect
  • High Fever


Nine years experience of introduction of Homeopathy at Headache Clinic of a major Public Hospital.


To reproduce the positive results of a previous study presented in EHTIC 2008.


One hundred and twenty migraine patients assigned to receive individualized homeopathic treatment. Additional evaluation by a neurologist was performed at baseline, 6 and 12 months. Primary and secondary measures of migraine severity and impact on quality of life were recorded and analyzed.


Eighty two patients opted only for homeopathic treatment until the completion of the study, with a baseline HIT-6 score of 67±4. Significant improvement was recorded at 6 months (HIT-6 45±8, P<0.0009 vs baseline, Wilcoxon signed ranks test), further established at 12 months (HIT-6 40.2±7, P<0.0009 vs 6 months). Migraine severity (VAS) decreased by 72% and frequency by 81 % at 12 months (P<0.0001 vs baseline). Observed potential adverse effects were an initial 'aggravation' of migraine symptoms in 69%, recurrence of past medical diseases ,especially infections or upper respiratory with high fever in 62%.


More positive results and more reappearance of high fever infections appeared in this study after following G.Vithoulkas’ instructions.

Original videos of many patients describing the unexpected reappearance of very high fever, after a long time, will be presented.

No conflict of interest.

Authors’ Affiliations

Headache Clinic, "G.Gennimatas" Athens General Hospital, Athens, Greece
Academic Dept, International Academy of Classical Homeopathy, Alonnisos, Greece


© Kivellos et al; licensee Springer. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.